Lenore Pharmaceuticals Private Limited, a active private limited company, was established on 16 October 2019 in Lucknow, Uttar Pradesh, India. Engaging in specialty within the trading sector, it holds CIN: U51909UP2019PTC122397. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Pramod Narain Sinha (Director), Shikha Srivastava (Director), Poonam Sinha (Director). Past directors included Ajai Kumar Srivastav, Ramesh Chandra Srivastava. It holds ₹3.75 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No-12 , Metro Plaza , Vivek Khand-2 Gomtinagar Lucknow Up India, Lucknow, Uttar Pradesh, 226010.
U51909UP2019PTC122397
122397
16 October 2019
₹1.00 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Lenore Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pramod Narain Sinha | Director | 16 Oct 2019 | Current |
| Shikha Srivastava | Director | 16 Oct 2019 | Current |
| Poonam Sinha | Director | 04 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Sep 2020 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lenore Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.25% increase. The company also saw a substantial improvement in profitability, with a 24.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 105.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Lenore Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹3,750,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Nov 2020 | Others | ₹3.75 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Lenore Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lenore Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lenore Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Poonam Sinha was appointed as a Director was appointed as a Director on 04 Sep 2025 & has been associated with this company since 2 months 24 days . was documented.
A charge with Others of Rs. 3.75 M registered on 25 Nov 2020 with Charge ID 100391984 was modified on 06 Feb 2025. was recorded as a recent event.
Progress on Lenore Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Lenore Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
A charge with Others amounted to Rs. 3.75 M with Charge ID 100391984 was registered on 25 Nov 2020. was recorded as a recent event.
The activity Pramod Narain Sinha was appointed as a Director was appointed as a Director on 16 Oct 2019 & has been associated with this company since 6 years 1 month . was completed.
The CIN of Lenore Pharmaceuticals Private Limited is U51909UP2019PTC122397.
Lenore Pharmaceuticals Private Limited is headquartered at Shop No-12 , Metro Plaza , Vivek Khand-2 Gomtinagar Lucknow Up India, Lucknow, Uttar Pradesh, 226010.
Lenore Pharmaceuticals Private Limited was incorporated on 16 October 2019.
The current directors of Lenore Pharmaceuticals Private Limited are
The primary industry of Lenore Pharmaceuticals Private Limited is Trading.
Lenore Pharmaceuticals Private Limited is unlisted.
The authorized capital of Lenore Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX